President’s FY 1992 Budget Seeks $1.81 Billion For NCI, 5.6% Increase, But $800M Below Byspass
In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei
Prevention, Centers To Gain, some $$ In President’s Budget
NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most
Gavel Changes Hands At NCAB, Korn advises New Members On Role
DCPC Advisors Upset At NCAB Over Why Decision, But Move On
Prevention & Control Study Section In DRG Requested By NCI
High Risk Youth Targeted In Concept Ok’d By Advisors
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
